Bank of America
MNTA

Bank of America’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bank of America’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-23,100
Closed -$456K – 7464
2019
Q4 		$456K Buy
+23,100
New +$369K ﹤0.01% 5066
2014
Q1 		– Sell
-88,100
Closed -$1.56M – 8237
2013
Q4 		$1.56M Hold
88,100
– – ﹤0.01% 3585
2013
Q3 		$1.27M Sell
88,100
-27,400
-24% -$419K ﹤0.01% 3711
2013
Q2 		$1.74M Buy
+115,500
New +$1.52M ﹤0.01% 3382

Bank of America's MNTA Position: Q4 2020 in Review

Bank of America sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 912,332 shares — an estimated $47.9M sold.

Bank of America first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $47.9M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Bank of America reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Bank of America sold 912,332 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $47.9M.
  • Bank of America first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
  • Bank of America's Momenta Pharmaceuticals, Inc. position peaked at $47.9M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Bank of America's 13F filing for Q4 2020, filed 10 Feb 2021.